Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

flumatinib MeSH Supplementary Concept Data 2026


MeSH Supplementary
flumatinib
Unique ID
C553360
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C553360
Entry Term(s)
4-(4-methylpiperazin-1-ylmethyl)-N-(6-methyl-5-(4-pyridin-3-ylpyrimidin-2-ylamino)pyridin-3-yl)-3-trifluoromethylbenzamide
HH-GV-678
HH-GV678
HHGV678
flumbatinib
Pharm Action
Tyrosine Kinase Inhibitors
Registry Numbers
R4009Y24AI
0
Previous Indexing
*PYRIDINES (2010)
Heading Mapped to
*Aminopyridines
*Benzamides
Frequency
11
Note
an antineoplastic agent and tyrosine kinase inhibitor
Source
Leukemia. 2010 Oct;24(10):1807-9
Date Introduced
2010/11/10
Last Updated
2023/08/04
flumatinib Preferred
HH-GV678 Narrower
page delivered in 0.004s